60 related articles for article (PubMed ID: 21191305)
1. Association of CYP1B1 gene polymorphisms with susceptibility to endometrial cancer: a meta-analysis.
Wang F; Zou YF; Sun GP; Su H; Huang F
Eur J Cancer Prev; 2011 Mar; 20(2):112-20. PubMed ID: 21191305
[TBL] [Abstract][Full Text] [Related]
2. Association of CYP1B1 L432V polymorphism with urinary cancer susceptibility: a meta-analysis.
Jiang W; Sun G; Xiong J; Xi X; Shi Z
Diagn Pathol; 2014 Jun; 9():113. PubMed ID: 24913727
[TBL] [Abstract][Full Text] [Related]
3. Association between HSD17B1 rs605059 polymorphisms and the risk of uterine diseases: a systemic review and meta-analysis.
Mu X; Du X; Yao K; Zhao J; Bian C; Wang Q; Ma H; Yi T; Wu Y; Zhao X
Int J Clin Exp Pathol; 2015; 8(6):6012-8. PubMed ID: 26261478
[TBL] [Abstract][Full Text] [Related]
4. Association between CCL5, CCL11, and CCL17 polymorphisms and atopic dermatitis risk: A systematic review and meta-analysis.
Zou C; Zhang W; Li M; He D; Han Y; Liu M; Lu M
Medicine (Baltimore); 2024 Feb; 103(8):e36897. PubMed ID: 38394497
[TBL] [Abstract][Full Text] [Related]
5. Association between IGF-1 polymorphisms and risk of osteoporosis in Chinese population: a meta-analysis.
Gao ST; Lv ZT; Zhou CK; Mao C; Sheng WB
BMC Musculoskelet Disord; 2018 May; 19(1):141. PubMed ID: 29747606
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in inflammation pathway genes and endometrial cancer risk.
Delahanty RJ; Xiang YB; Spurdle A; Beeghly-Fadiel A; Long J; Thompson D; Tomlinson I; Yu H; Lambrechts D; Dörk T; Goodman MT; Zheng Y; Salvesen HB; Bao PP; Amant F; Beckmann MW; Coenegrachts L; Coosemans A; Dubrowinskaja N; Dunning A; Runnebaum IB; Easton D; Ekici AB; Fasching PA; Halle MK; Hein A; Howarth K; Gorman M; Kaydarova D; Krakstad C; Lose F; Lu L; Lurie G; O'Mara T; Matsuno RK; Pharoah P; Risch H; Corssen M; Trovik J; Turmanov N; Wen W; Lu W; Cai Q; Zheng W; Shu XO
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):216-23. PubMed ID: 23221126
[TBL] [Abstract][Full Text] [Related]
7. Association between the NBS1 E185Q polymorphism and cancer risk: a meta-analysis.
Lu M; Lu J; Yang X; Yang M; Tan H; Yun B; Shi L
BMC Cancer; 2009 Apr; 9():124. PubMed ID: 19393077
[TBL] [Abstract][Full Text] [Related]
8. Functional variant rs10175368 which affects the expression of CYP1B1 plays a protective role against breast cancer in a Chinese Han population.
Liu J; Zhang L; Tang M; Chen X; Yang C; Li Y; Feng J; Deng Y; Wang X; Zhang Y
Eur J Cancer Prev; 2023 Sep; 32(5):450-459. PubMed ID: 37038992
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of Italian patients with congenital glaucoma.
Giuffre' I
Ophthalmic Genet; 2011 Aug; ():. PubMed ID: 21815720
[TBL] [Abstract][Full Text] [Related]
10. Multilocus analysis of SNP and metabolic data within a given pathway.
Kristensen VN; Tsalenko A; Geisler J; Faldaas A; Grenaker GI; Lingjaerde OC; Fjeldstad S; Yakhini Z; Lønning PE; Børresen-Dale AL
BMC Genomics; 2006 Jan; 7():5. PubMed ID: 16412218
[TBL] [Abstract][Full Text] [Related]
11. Correlation between heparanase gene polymorphism and susceptibility to endometrial cancer.
Cao H; Yang S; Yu X; Xi M
Mol Genet Genomic Med; 2020 Oct; 8(10):e1257. PubMed ID: 32869952
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of
He S; Cao R; Mao Y; Li N; Wang Y; Ma H; Tian K
J Gynecol Oncol; 2023 May; 34(3):e40. PubMed ID: 36731897
[TBL] [Abstract][Full Text] [Related]
13. Association of PDCD6 polymorphisms with the risk of cancer: Evidence from a meta-analysis.
Hashemi M; Bahari G; Markowski J; Małecki A; Łos MJ; Ghavami S
Oncotarget; 2018 May; 9(37):24857-24868. PubMed ID: 29872511
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of CYP1B1, oxidative stress and phase II detoxification enzyme status in oral cancer progression model.
Bartake AR; Sarode S; Palaskar S; Girme A; Sarode G; Kamble S; Narang B; Bhale P
J Oral Biol Craniofac Res; 2024; 14(2):169-174. PubMed ID: 38384675
[TBL] [Abstract][Full Text] [Related]
15. Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer.
Wei R; De Vivo I; Huang S; Zhu X; Risch H; Moore JH; Yu H; Garmire LX
Oncotarget; 2016 Aug; 7(34):55249-55263. PubMed ID: 27409342
[TBL] [Abstract][Full Text] [Related]
16. Betaglycan Gene (
Zakrzewski PK; Forma E; Cygankiewicz AI; Bryś M; Wójcik-Krowiranda K; Bieńkiewicz A; Semczuk A; Krajewska WM
J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32987826
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis on Asymptomatic Endometrial Thickening and Its Association with Endometrial Cancer Risk in Women Over 50 Years of Age.
Cai J; Huang Y; Li Q
Altern Ther Health Med; 2024 Jan; ():. PubMed ID: 38330563
[TBL] [Abstract][Full Text] [Related]
18. CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.
Zhang H; Li L; Xu Y
PLoS One; 2013; 8(7):e68634. PubMed ID: 23861929
[TBL] [Abstract][Full Text] [Related]
19. Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.
Liu JY; Yang Y; Liu ZZ; Xie JJ; Du YP; Wang W
Mol Genet Genomics; 2015 Apr; 290(2):739-65. PubMed ID: 25475389
[TBL] [Abstract][Full Text] [Related]
20. Association of CYP1B1 gene polymorphisms and the positive expression of estrogen alpha and estrogen beta with endometrial cancer risk.
Zhu ZY; Mu YQ; Fu XM; Li SM; Zhao FX
Eur J Gynaecol Oncol; 2011; 32(2):188-91. PubMed ID: 21614911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
